… Regeneron Pharmaceuticals Shares New Developments in Phase 3 Melanoma Study of Fianlimab Combination; ENHERTU Gains Two New US Indications …
Generative AI in Drug Discovery: Transforming Pharma R&D
calendar_today
May 25, 2026
domain
regeneron-pharmaceuticals